Home | BSAAM's Organizer | BSAAM's Sponsor | Contact Us
AACL AACL AACL AACL
BSAAM Logo
AACL Logo
Anti Ageing Conference London 2020
Follow us on ...
Facebook  Twitter  Instagram
Conference Information
Register Info
   
Delegate Information
   
A4M Board Certification
  American Board Of Anti-Aging/Regenerative Medicine (ABAARM)
   
Past Conference Information
  2018
2018 Speakers and Presentations
2018 Programme
2018 Exhibitors

BSAAMs AACL 2018 Peer Review Board Members
  2017
2017 Speakers and Presentations
2017 Programme
2017 Exhibitors

BSAAMs AACL 2017 Peer Review Board Members
  2016
2016 Speakers and Presentations
2016 Programme
2016 Exhibitors
2016 Moderators
BSAAMs AACL 2016 Peer Review Board Members
  2015
2015 Speakers and Presentations
2015 Programme
2015 Exhibitors
2015 Moderators
BSAAMs AACL 2015 Peer Review Board Members
  2014
2014 Speakers and Presentations
2014 Programme
2014 Exhibitors
2014 Moderators
2014 Peer Review Board Members
2014 Aesthetic Peer Review Board Members
  2013
2013 Speakers and Presentations
2013 Programme
2013 Exhibitors
2013 Moderators
2013 Peer Review Board Members
2013 Aesthetic Peer Review Board Members
  2012
2012 Speakers and Presentations
2012 Programme
2012 Exhibitors
2012 Moderators
2012 Peer Review Board Members
2012 Aesthetic Peer Review Board Members
  2011
2011 Speakers and Presentations
2011 Programme
2011 Exhibitors
2011 Moderators
2011 Peer Review Board Members
2011 Aesthetic Peer Review Board Members
  2010
2010 Conference Manual
2010 Speakers and Presentations
2010 Programme
2010 Exhibitors
2010 Moderators
2010 Peer Review Board Members
2010 Aesthetic Peer Review Board Members
  2009
Programme for the 2009
Exhibitors for the 2009
Speakers for the 2009
2009 Peer Review Board Members
2009 Aesthetic Peer Review Board Members
  2008
Programme for 2008
Exhibitors for 2008
Speakers for 2008
2008 Peer Review Board Members
2008 Aesthetic Peer Review Board Members
  2007
  2007 Speaker List
2007 Speaker Programme
  Pre Conference Workshops
Sept 12 Pre-Conference Workshop Programme
Sept 13 Pre-Conference Workshop Programme
  2007 Peer Review Board Members
  Exhibitors for 2007
  2006
  3rd Annual Anti-Ageing Conference Manual (2006)
  Programme for 2006
  ISRM2006 Scientific Board Members
  2006 Peer Review Board Members
  Exhibitors 2006
  2005
  Post Review of 2005
  Remarks about 2005
  Peer Review Board of 2005
  Past Speakers 2005
  2004
  Past Speakers 2004
  2002
  Past Speakers Monte Carlo 2002
   
BSAAM's AACL Organizer
BSAAM
BSAAM Affiliates
waaam
   
   
A4M
   
wosaam
AACL Supporters
HB Health
www.hbhealth.com
   
CPD
   
  BANT
   
 
   
 
   
  Sun Chlorella
   
 
   
enerzona
   
BHMA
   
WOCPM
   
FACE
   
IAAS
   
Dole
   
 
   
 
   
   

AACL 2005 Speaker

Dr. Fritz H. Bach MD
Dr. Fritz Bach, born in Vienna, Austria, attended Harvard College and Harvard Medical School, took an internal medicine residency, and since 1963 has done research at the University of Wisconsin, Madison, the University of Minnesota, Minneapolis and now Harvard Medical School in Boston. He has worked in genetics, immunology and recently vascular biology, with much of his work devoted to studies of transplantation. He described the mixed leukocyte culture (MLC) test for matching donors and recipients for transplantation, which led to his contributing to the description of the major histocompatibility complex (MHC) in humans (HLA), heading the team that did the first successful matched bone marrow transplant, defining the existence of class II loci and their antigens and establishing the existence of two types of antigens with different functions associated with the MHC.

His work in xenotransplantation included his suggestion that endothelial cell activation is the key role in xenograft rejection and, with his colleague Augustin Dalmasso, to suggest that transgenic pigs expressing a human gene to block human complement may help solve xenograft rejection. As a part of the progress in xenotransplantation, he suggested that endothelial cells might express protective genes that help to avoid rejection, which he and his colleagues have not shown to be true.

Dr. Bach has received numerous awards, including Peter Medawar Prize of the International Transplantation Society and the most recent which is the Doctor of Medicine, Honoris Causa, 2005 from the University of Vienna.

The Body's Molecules Provide their own Best Protection Against Ageing
Heme oxygenase?1 (HO?1) breaks down heme to yield carbon monoxide (CO) and
biliverdin/bilirubin, two molecules that have been viewed as toxic. Recent evidence,
suggests that CO and bilirubin can be beneficial in humans. Individuals who have high
normal levels of bilirubin have less atherosclerotic events as compared with those
individuals with low normal bilirubin. The HO?1 system may well act to prevent tissue
aging by the protective functions of the products of heme degradation.

Goals and Objectives:

  • 1. To introduce the audience to the concept of protective genes that maintain homeostasis.
  • 2. To discuss the endogenous activities of physiological molecules that appear to prevent tissue damage.
  • 3. To focus on the potential negative effects of unfettered inflammation.
  • 4. To evaluate the preserving properties of bilirubin.

Home | BSAAM's Organizer | BSAAM's Sponsor | Contact Us
BSAAM's Anti Ageing Conference London, 38 Regent on the River
William Morris Way London SW6 2UT, United Kingdom
Tel: +44 (0)79 7317 3478  Fax: +44 (0)20 7491 0410
Emails :
london@antiageingconference.com
mariasomers@bsaam.com